Related Experiment Video
Updated: Jun 20, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Genetic susceptibility to distinct bladder cancer subphenotypes
Lin T Guey1, Montserrat García-Closas, Cristiane Murta-Nascimento
1Spanish National Cancer Research Centre, Madrid, Spain.
Germline genetic variations may influence bladder cancer subphenotypes. Specific genetic loci, like PMS2-rs6463524 and CD4-rs3213427, showed associations with muscle-invasive bladder tumors, suggesting a link to cancer diversity.
Area of Science:
- Genetics
- Oncology
- Cancer Heterogeneity
Background:
- Bladder cancer exhibits heterogeneity with distinct subphenotypes.
- These subphenotypes are associated with varying prognoses.
- Genetic susceptibility patterns may correlate with specific bladder cancer subphenotypes.
Purpose of the Study:
- To investigate the role of germline genetic variation in bladder cancer heterogeneity.
- To identify specific genetic variants associated with different bladder cancer subphenotypes.
Main Methods:
- A case-control study (Spanish Bladder Cancer/EPICURO Study) involving 1526 candidate variants in 423 genes.
- Classification of bladder cancer into three subphenotypes: low-grade nonmuscle invasive, high-grade nonmuscle invasive, and muscle invasive.
- Polytomous risk models were used to assess variant associations with subphenotypes, adjusting for confounders.
Main Results:
- Established susceptibility genotypes (NAT2, GSTM1) showed similar associations across subphenotypes.
- Variants PMS2-rs6463524 and CD4-rs3213427 were associated with muscle-invasive tumors but not non-muscle-invasive tumors.
- These associations suggest heterogeneity in genetic susceptibility among bladder cancer subphenotypes.
Conclusions:
- Exploratory findings suggest a potential link between genetic susceptibility loci and the molecular/pathologic diversity of bladder cancer.
- Further validation through large-scale replication studies is necessary.
- Additional research on other genes and single nucleotide polymorphisms is recommended.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
